In a murine model of rheumatoid arthritis, Haikal et al. [133] demonstrated that IL-4-enhanced MSCs attenuate joint damage by downregulating pro-inflammatory cytokines (e.g., TNF-α, MCP-1), reducing autoantibody levels, and protecting cartilage from structural erosion. The gene discussed is IL4; the disease is rheumatoid arthritis.